What have we learned about GPER function in physiology and disease from knockout mice?

Journal of Steroid Biochemistry and Molecular Biology

Volumn 153, Issue , 2015, Pages 114-126

  Prossnitz, Eric R ^a,b   Hathaway, Helen J ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cancer; Cardiovascular; Diabetes; Estrogen; Immune; Metabolism; Obesity; Receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; ESTROGEN RECEPTOR;

ATHEROSCLEROSIS; BREAST CARCINOGENESIS; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASES; DISTANT METASTASIS; ESTROGEN ACTIVITY; EX VIVO STUDY; GLUCOSE INTOLERANCE; HEART INFARCTION; HYPERTENSION; IMMUNE SYSTEM; IMMUNITY; IN VIVO STUDY; INSULIN RESISTANCE; KIDNEY FUNCTION; KNOCKOUT MOUSE; MAMMARY GLAND; METABOLIC REGULATION; MULTIPLE SCLEROSIS; MUSCULOSKELETAL FUNCTION; NEOPLASM; NERVOUS SYSTEM FUNCTION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CARDIOVASCULAR DISEASE; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY; MICE; MICE, KNOCKOUT; NEOPLASMS; OBESITY; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84941168439     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.06.014     Document Type: Review

References (198)

1. K. Dahlman-Wright, V. Cavailles, S.A. Fuqua, V.C. Jordan, J.A. Katzenellenbogen, K.S. Korach, A. Maggi, M. Muramatsu, M.G. Parker, and J.A. Gustafsson International union of pharmacology. LXIV. Estrogen receptors Pharmacol. Rev. 58 4 2006 773 781
2. E.R. Prossnitz, and M. Barton The G-protein-coupled estrogen receptor GPER in health and disease Nat. Rev. Endocrinol. 7 12 2011 715 726
3. E.R. Prossnitz, and J.B. Arterburn International union of basic and clinical pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacologic modulators Pharmacol. Rev. 67 2015 505 540
4. E.R. Prossnitz, and M. Barton Estrogen biology: new insights into GPER function and clinical opportunities Mol. Cell. Endocrinol. 389 1-2 2014 71 83
5. H. Macias, and L. Hinck Mammary gland development Wiley Interdiscip. Rev. Dev. Biol. 1 4 2012 533 557
6. D.P. Edwards Regulation of signal transduction pathways by estrogen and progesterone Annu. Rev. Physiol. 67 2005 335 376
7. G. Lombardi, S. Zarrilli, A. Colao, L. Paesano, C. Di Somma, F. Rossi, and M. De Rosa Estrogens and health in males Mol. Cell. Endocrinol. 178 1-2 2001 51 55
8. J.S. Finkelstein, H. Lee, S.A. Burnett-Bowie, J.C. Pallais, E.W. Yu, L.F. Borges, B.F. Jones, C.V. Barry, K.E. Wulczyn, B.J. Thomas, and B.Z. Leder Gonadal steroids and body composition, strength, and sexual function in men N. Engl. J. Med. 369 11 2013 1011 1022
9. J.R. Rettberg, J. Yao, and R.D. Brinton Estrogen: a master regulator of bioenergetic systems in the brain and body Front. Neuroendocrinol. 35 1 2013 8 30
10. J.H. Kim, H.T. Cho, and Y.J. Kim The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation Endocr. J. 61 11 2014 1055 1067
11. F. Mauvais-Jarvis, D.J. Clegg, and A.L. Hevener The role of estrogens in control of energy balance and glucose homeostasis Endocr. Rev. 34 3 2013 309 338
12. A.A. Knowlton, and A.R. Lee Estrogen and the cardiovascular system Pharmacol. Ther. 135 1 2012 54 70
13. B.S. McEwen, K.T. Akama, J.L. Spencer-Segal, T.A. Milner, and E.M. Waters Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms Behav. Neurosci. 126 1 2012 4 16
14. Y. Imai, M.Y. Youn, K. Inoue, I. Takada, A. Kouzmenko, and S. Kato Nuclear receptors in bone physiology and diseases Physiol. Rev. 93 2 2013 481 523
15. M. Cunningham, and G. Gilkeson Estrogen receptors in immunity and autoimmunity Clin. Rev. Allergy Immunol. 40 1 2011 66 73
16. E.V. Jensen, and E.R. DeSombre Estrogen-receptor interaction Science 182 108 1973 126 134
17. E.V. Jensen, and H.I. Jacobson Basic guides to the mechanism of estrogen action Recent Prog. Horm. Res. 18 1962 387 414
18. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. U. S. A. 93 12 1996 5925 5930
19. J.S. Carroll, and M. Brown Estrogen receptor target gene: an evolving concept Mol. Endocrinol. 20 8 2006 1707 1714
20. J.R. Schultz-Norton, Y.S. Ziegler, and A.M. Nardulli ERalpha-associated protein networks Trends Endocrinol. Metab. 22 4 2011 124 129
21. C.M. Szego, and J.S. Davis Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen Proc. Natl. Acad. Sci. U. S. A. 58 4 1967 1711 1718
22. R.J. Pietras, and C.M. Szego Endometrial cell calcium and oestrogen action Nature 253 5490 1975 357 359
23. T.P. Burris, L.A. Solt, Y. Wang, C. Crumbley, S. Banerjee, K. Griffett, T. Lundasen, T. Hughes, and D.J. Kojetin Nuclear receptors and their selective pharmacologic modulators Pharmacol. Rev. 65 2 2013 710 778
24. E.J. Filardo, J.A. Quinn, K.I. Bland, and A.R. Frackelton Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol. Endocrinol. 14 10 2000 1649 1660
25. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 5715 2005 1625 1630
26. P. Thomas, Y. Pang, E.J. Filardo, and J. Dong Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2 2005 624 632
27. D.M. Rosenbaum, S.G. Rasmussen, and B.K. Kobilka The structure and function of G-protein-coupled receptors Nature 459 7245 2009 356 363
28. E.J. Filardo, and P. Thomas Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology Endocrinology 153 7 2012 2953 2962
29. E.R. Prossnitz, J.B. Arterburn, H.O. Smith, T.I. Oprea, L.A. Sklar, and H.J. Hathaway Estrogen signaling through the transmembrane G protein-coupled receptor GPR30 Annu. Rev. Physiol. 70 2008 165 190
30. S.R. Hammes, and E.R. Levin Minireview: recent advances in extranuclear steroid receptor actions Endocrinology 152 12 2011 4489 4495
31. E.R. Prossnitz, and M. Maggiolini Mechanisms of estrogen signaling and gene expression via GPR30 Mol. Cell. Endocrinol. 308 1-2 2009 32 38
32. L. Orlando, P. Schiavone, P. Fedele, N. Calvani, A. Nacci, P. Rizzo, A. Marino, M. D'Amico, F. Sponziello, E. Mazzoni, M. Cinefra, N. Fazio, E. Maiello, N. Silvestris, G. Colucci, and S. Cinieri Molecularly targeted endocrine therapies for breast cancer Cancer Treat. Rev. 36 Suppl. 3 2011 S67 S71
33. D.P. McDonnell, and S.E. Wardell The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer Curr. Opin. Pharmacol. 10 6 2010 620 628
34. S.R. Stauffer, C.J. Coletta, R. Tedesco, G. Nishiguchi, K. Carlson, J. Sun, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists J. Med. Chem. 43 26 2000 4934 4947
35. M.J. Meyers, J. Sun, K.E. Carlson, G.A. Marriner, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues J. Med. Chem. 44 24 2001 4230 4251
36. W.K. Petrie, M.K. Dennis, C. Hu, D. Dai, J.B. Arterburn, H.O. Smith, H.J. Hathaway, and E.R. Prossnitz G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth Obstet. Gynecol. Int. 2013 2013 472720
37. C.G. Bologa, C.M. Revankar, S.M. Young, B.S. Edwards, J.B. Arterburn, A.S. Kiselyov, M.A. Parker, S.E. Tkachenko, N.P. Savchuck, L.A. Sklar, T.I. Oprea, and E.R. Prossnitz Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat. Chem. Biol. 2 4 2006 207 212
38. M.K. Dennis, A.S. Field, R. Burai, C. Ramesh, W.K. Petrie, C.G. Bologa, T.I. Oprea, Y. Yamaguchi, S. Hayashi, L.A. Sklar, H.J. Hathaway, J.B. Arterburn, and E.R. Prossnitz Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity J. Steroid Biochem. Mol. Biol. 127 3-5 2011 358 366
39. M.K. Dennis, R. Burai, C. Ramesh, W.K. Petrie, S.N. Alcon, T.K. Nayak, C.G. Bologa, A. Leitao, E. Brailoiu, E. Deliu, N.J. Dun, L.A. Sklar, H.J. Hathaway, J.B. Arterburn, T.I. Oprea, and E.R. Prossnitz In vivo effects of a GPR30 antagonist Nat. Chem. Biol. 5 6 2009 421 427
40. E. Blasko, C.A. Haskell, S. Leung, G. Gualtieri, M. Halks-Miller, M. Mahmoudi, M.K. Dennis, E.R. Prossnitz, W.J. Karpus, and R. Horuk Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis J. Neuroimmunol. 214 1-2 2009 67 77
41. Y. Gui, Z. Shi, Z. Wang, J.J. Li, C. Xu, R. Tian, X. Song, M.P. Walsh, D. Li, J. Gao, and X.L. Zheng The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER J. Cell. Physiol. 230 4 2015 885 895
42. C. Wang, X. Lv, C. He, G. Hua, M.Y. Tsai, and J.S. Davis The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization Cell Death Dis. 4 2013 e869
43. A. Holm, P.O. Grande, R.F. Luduena, B. Olde, V. Prasad, L.M. Leeb-Lundberg, and B.O. Nilsson The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner Mol. Cell. Biochem. 366 1-2 2012 239 249
44. E. Lounkine, M.J. Keiser, S. Whitebread, D. Mikhailov, J. Hamon, J.L. Jenkins, P. Lavan, E. Weber, A.K. Doak, S. Cote, B.K. Shoichet, and L. Urban Large-scale prediction and testing of drug activity on side-effect targets Nature 486 7403 2012 361 367
45. K.S. Korach Insights from the study of animals lacking functional estrogen receptor Science 266 5190 1994 1524 1527
46. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 19 2000 4277 4291
47. J.H. Krege, J.B. Hodgin, J.F. Couse, E. Enmark, M. Warner, J.F. Mahler, M. Sar, K.S. Korach, J.A. Gustafsson, and O. Smithies Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc. Natl. Acad. Sci. U. S. A. 95 26 1998 15677 15682
48. M.C. Antal, A. Krust, P. Chambon, and M. Mark Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant Proc. Natl. Acad. Sci. U. S. A. 105 7 2008 2433 2438
49. C. Otto, I. Fuchs, G. Kauselmann, H. Kern, B. Zevnik, P. Andreasen, G. Schwarz, H. Altmann, M. Klewer, M. Schoor, R. Vonk, and K.H. Fritzemeier GPR30 does not mediate estrogenic responses in reproductive organs in mice Biol. Reprod. 80 1 2009 34 41
50. U.E. Martensson, S.A. Salehi, S. Windahl, M.F. Gomez, K. Sward, J. Daszkiewicz-Nilsson, A. Wendt, N. Andersson, P. Hellstrand, P.O. Grande, C. Owman, C.J. Rosen, M.L. Adamo, I. Lundquist, P. Rorsman, B.O. Nilsson, C. Ohlsson, B. Olde, and L.M. Leeb-Lundberg Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice Endocrinology 150 2 2009 687 698
51. J. Isensee, L. Meoli, V. Zazzu, C. Nabzdyk, H. Witt, D. Soewarto, K. Effertz, H. Fuchs, V. Gailus-Durner, D. Busch, T. Adler, M.H. de Angelis, M. Irgang, C. Otto, and P.R. Noppinger Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice Endocrinology 150 4 2009 1722 1730
52. C. Wang, B. Dehghani, I.J. Magrisso, E.A. Rick, E. Bonhomme, D.B. Cody, L.A. Elenich, S. Subramanian, S.J. Murphy, M.J. Kelly, J.S. Rosenbaum, A.A. Vandenbark, and H. Offner GPR30 contributes to estrogen-induced thymic atrophy Mol. Endocrinol. 22 3 2008 636 648
53. E.R. Levin G protein-coupled receptor 30: estrogen receptor or collaborator Endocrinology 150 4 2009 1563 1565
54. J.F. Couse, and K.S. Korach Contrasting phenotypes in reproductive tissues of female estrogen receptor null mice Ann. N. Y. Acad. Sci. 948 2001 1 8
55. K.J. Hamilton, Y. Arao, and K.S. Korach Estrogen hormone physiology: reproductive findings from estrogen receptor mutant mice Reprod. Biol. 14 1 2014 3 8
56. J.F. Couse, S.C. Hewitt, D.O. Bunch, M. Sar, V.R. Walker, B.J. Davis, and K.S. Korach Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta Science 286 1999 2328 2331
57. V.R. Walker, and K.S. Korach Estrogen receptor knockout mice as a model for endocrine research ILAR J. 45 4 2004 455 461
58. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc. Natl. Acad. Sci. U. S. A. 90 23 1993 11162 11166
59. S. Ogawa, V. Eng, J. Taylor, D.B. Lubahn, K.S. Korach, and D.W. Pfaff Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice Endocrinology 139 12 1998 5070 5081
60. E.F. Rissman, A.H. Early, J.A. Taylor, K.S. Korach, and D.B. Lubahn Estrogen receptors are essential for female sexual receptivity Endocrinology 138 1 1997 507 510
61. J.F. Couse, M.M. Yates, V.R. Walker, and K.S. Korach Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERalpha but not ERbeta Mol. Endocrinol. 17 6 2003 1039 1053
62. E.M. Eddy, T.F. Washburn, D.O. Bunch, E.H. Goulding, B.C. Gladen, D.B. Lubahn, and K.S. Korach Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility Endocrinology 137 11 1996 4796 4805
63. J.F. Couse, S.W. Curtis, T.F. Washburn, E.M. Eddy, D.W. Schomberg, and K.S. Korach Disruption of the mouse oestrogen receptor gene: resulting phenotypes and experimental findings Biochem. Soc. Trans. 23 4 1995 929 935
64. W.P. Bocchinfuso, and K.S. Korach Mammary gland development and tumorigenesis in estrogen receptor knockout mice J. Mamm. Gland Biol. Neopl. 2 4 1997 323 334
65. S.C. Hewitt, and K.S. Korach Estrogen receptors: structure, mechanisms and function Rev. Endocr. Metab. Disord. 3 3 2002 193 200
66. O. Vidal, M. Lindberg, L. Savendahl, D.B. Lubahn, E.M. Ritzen, J.A. Gustafsson, and C. Ohlsson Disproportional body growth in female estrogen receptor-alpha-inactivated mice Biochem. Biophys. Res. Commun. 265 2 1999 569 571
67. O. Vidal, M.K. Lindberg, K. Hollberg, D.J. Baylink, G. Andersson, D.B. Lubahn, S. Mohan, J.A. Gustafsson, and C. Ohlsson Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice Proc. Natl. Acad. Sci. U. S. A. 97 10 2000 5474 5479
68. J.B. Hodgin, J.H. Krege, R.L. Reddick, K.S. Korach, O. Smithies, and N. Maeda Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice J. Clin. Invest. 107 3 2001 333 340
69. P.A. Heine, J.A. Taylor, G.A. Iwamoto, D.B. Lubahn, and P.S. Cooke Increased adipose tissue in male and female estrogen receptor-alpha knockout mice Proc. Natl. Acad. Sci. U. S. A. 97 23 2000 12729 12734
70. R. O'Lone, K. Knorr, I.Z. Jaffe, M.E. Schaffer, P.G. Martini, R.H. Karas, J. Bienkowska, M.E. Mendelsohn, and U. Hansen Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species Mol. Endocrinol. 21 6 2007 1281 1296
71. C. Forster, S. Makela, A. Warri, S. Kietz, D. Becker, K. Hultenby, M. Warner, and J.A. Gustafsson Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium Proc. Natl. Acad. Sci. U. S. A. 99 24 2002 15578 15583
72. O. Imamov, A. Morani, G.J. Shim, Y. Omoto, C. Thulin-Andersson, M. Warner, and J.A. Gustafsson Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate Proc. Natl. Acad. Sci. U. S. A. 101 25 2004 9375 9380
73. Z. Weihua, S. Makela, L.C. Andersson, S. Salmi, S. Saji, J.I. Webster, E.V. Jensen, S. Nilsson, M. Warner, and J.A. Gustafsson A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc. Natl. Acad. Sci. U. S. A. 98 11 2001 6330 6335
74. J.F. Couse, S.W. Curtis, T.F. Washburn, J. Lindzey, T.S. Golding, D.B. Lubahn, O. Smithies, and K.S. Korach Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene Mol. Endocrinol. 9 1995 1441 1454
75. P.J. Shughrue, G.R. Askew, T.L. Dellovade, and I. Merchenthaler Estrogen-binding sites and their functional capacity in estrogen receptor double knockout mouse brain Endocrinology 143 5 2002 1643 1650
76. S.K. Das, J. Tan, S. Raja, J. Halder, B.C. Paria, and S.K. Dey Estrogen targets genes involved in protein processing, calcium homeostasis, and Wnt signaling in the mouse uterus independent of estrogen receptor-alpha and -beta J. Biol. Chem. 275 37 2000 28834 28842
77. X. Hou, Y. Tan, M. Li, S.K. Dey, and S.K. Das Canonical Wnt signaling is critical to estrogen-mediated uterine growth Mol. Endocrinol. 18 12 2004 3035 3049
78. S.C. Hewitt, G.E. Kissling, K.E. Fieselman, F.L. Jayes, K.E. Gerrish, and K.S. Korach Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene FASEB J. 24 12 2010 4660 4667
79. J.C. Bopassa, R. Lu, H. Singh, B. Olde, A. Krust, L.F. Leeb-Lundberg, L. Toro, and E. Stefani G protein-coupled estrogen receptor 1, but not estrogen receptors alpha and beta, mediates rapid estrogen-induced cardioprotection during ischemia/reperfusion injury in male mice Biophys. J. 102 3, Suppl. 1 2012 141a
80. A.C. Villablanca, A. Tenwolde, M. Lee, M. Huck, S. Mumenthaler, and J.C. Rutledge 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice J. Cardiovasc. Transl. Res. 2 3 2009 289 299
81. J.B. Hodgin, and N. Maeda Minireview: estrogen and mouse models of atherosclerosis Endocrinology 143 12 2002 4495 4501
82. S. Liu, C. Le May, W.P. Wong, R.D. Ward, D.J. Clegg, M. Marcelli, K.S. Korach, and F. Mauvais-Jarvis Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival Diabetes 58 10 2009 2292 2302
83. C. Otto, B. Rohde-Schulz, G. Schwarz, I. Fuchs, M. Klewer, D. Brittain, G. Langer, B. Bader, K. Prelle, R. Nubbemeyer, and K.H. Fritzemeier GPR30 localizes to the endoplasmic reticulum and is not activated by estradiol Endocrinology 149 2008 4846 4856
84. F. Gao, X. Ma, A.B. Ostmann, and S.K. Das GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ER{alpha}) phosphorylation signals Endocrinology 152 4 2011 1434 1447
85. S. Sakiani, N.J. Olsen, and W.J. Kovacs Gonadal steroids and humoral immunity Nat. Rev. Endocrinol. 9 1 2013 56 62
86. R.S. Bonds, and T. Midoro-Horiuti Estrogen effects in allergy and asthma Curr. Opin. Allergy Clin. Immunol. 13 1 2013 92 99
87. A. Ray, and M. Ficek Immunomodulatory effects of anti-estrogenic drugs Acta Pharm. 62 2 2012 141 155
88. J.A. Rettew, S.H. t. McCall, and I. Marriott GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages Mol. Cell. Endocrinol. 328 1-2 2010 87 92
89. I. Cabas, M.C. Rodenas, E. Abellan, J. Meseguer, V. Mulero, and A. Garcia-Ayala Estrogen signaling through the G protein-coupled estrogen receptor regulates granulocyte activation in fish J. Immunol. 191 9 2013 4628 4639
90. A.B. Pernis Estrogen and CD4+ T cells Curr. Opin. Rheumatol. 19 5 2007 414 420
91. J.E. Staples, T.A. Gasiewicz, N.C. Fiore, D.B. Lubahn, K.S. Korach, and A.E. Silverstone Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations J. Immunol. 163 8 1999 4168 4174
92. M.C. Erlandsson, C. Ohlsson, J.A. Gustafsson, and H. Carlsten Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus Immunology 103 1 2001 17 25
93. S.H. Windahl, N. Andersson, A.S. Chagin, U.E. Martensson, H. Carlsten, B. Olde, C. Swanson, S. Moverare-Skrtic, L. Savendahl, M.K. Lagerquist, L.M. Leeb-Lundberg, and C. Ohlsson The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice Am. J. Physiol. Endocrinol. Metab. 296 3 2009 E490 E496
94. M. Niino, M. Hirotani, T. Fukazawa, S. Kikuchi, and H. Sasaki Estrogens as potential therapeutic agents in multiple sclerosis Cent. Nerv. Syst. Agents Med. Chem. 9 2 2009 87 94
95. J. Derwenskus, and F.D. Lublin Future treatment approaches to multiple sclerosis Handb. Clin. Neurol. 122 2014 563 577
96. A. Matejuk, A.C. Bakke, C. Hopke, J. Dwyer, A.A. Vandenbark, and H. Offner Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis J. Neurosci. Res. 77 1 2004 119 126
97. H. Offner Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis J. Neurosci. Res. 78 5 2004 603 624
98. C. Wang, B. Dehghani, Y. Li, L.J. Kaler, T. Proctor, A.A. Vandenbark, and H. Offner Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1 J. Immunol. 182 5 2009 3294 3303
99. M.A. Yates, Y. Li, P.J. Chlebeck, and H. Offner GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol BMC Immunol. 11 2010 20
100. S. Subramanian, L.M. Miller, M.R. Grafe, A.A. Vandenbark, and H. Offner Contribution of GPR30 for 1,25 dihydroxyvitamin D(3) protection in EAE Metab. Brain Dis. 27 1 2012 29 35
101. G. Sharma, C. Hu, J.L. Brigman, G. Zhu, H.J. Hathaway, and E.R. Prossnitz GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state Endocrinology 154 11 2013 4136 4145
102. R.L. Brunsing, and E.R. Prossnitz Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1 Immunology 134 1 2011 93 106
103. R.L. Brunsing, K.S. Owens, and E.R. Prossnitz The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions J. Immunother. 36 3 2013 190 196
104. M. Barton, and M.R. Meyer Postmenopausal hypertension: mechanisms and therapy Hypertension 54 1 2009 11 18
105. S. Chakrabarti, J.S. Morton, and S.T. Davidge Mechanisms of Estrogen Effects on the Endothelium: An Overview Can. J. Cardiol. 30 7 2013 705 712
106. C. Maric-Bilkan, E.L. Gilbert, and M.J. Ryan Impact of ovarian function on cardiovascular health in women: focus on hypertension Int. J. Womens Health 6 2014 131 139
107. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. O'Sullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, L. Van Horn, J. Wactawski-Wende, R. Wallace, and S. Wassertheil-Smoller Women's health initiative steering, effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 14 2004 1701 1712
108. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene, and I. Writing Group for the Women's Health Initiative Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 3 2002 321 333
109. E.P. Gurney, M.J. Nachtigall, L.E. Nachtigall, and F. Naftolin The women's health initiative trial and related studies: 10 years later: a clinician's view J. Steroid Biochem. Mol. Biol. 142 2014 4 11
110. X.P. Yang, and J.F. Reckelhoff Estrogen, hormonal replacement therapy and cardiovascular disease Curr. Opin. Nephrol. Hypertens. 20 2 2011 133 138
111. E. Haas, I. Bhattacharya, E. Brailoiu, M. Damjanovic, G.C. Brailoiu, X. Gao, L. Mueller-Guerre, N.A. Marjon, A. Gut, R. Minotti, M.R. Meyer, K. Amann, E. Ammann, A. Perez-Dominguez, M. Genoni, D.J. Clegg, N.J. Dun, T.C. Resta, E.R. Prossnitz, and M. Barton Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity Circ. Res. 104 3 2009 288 291
112. M. Delbeck, S. Golz, R. Vonk, W. Janssen, T. Hucho, J. Isensee, S. Schafer, and C. Otto Impaired left-ventricular cardiac function in male GPR30-deficient mice Mol. Med. Rep. 4 1 2011 37 40
113. L. Meoli, J. Isensee, V. Zazzu, C.S. Nabzdyk, D. Soewarto, H. Witt, A. Foryst-Ludwig, U. Kintscher, and P.R. Noppinger Sex- and age-dependent effects of GPR30 genetic deletion on the metabolic and cardiovascular profiles of diet-induced obese mice Gene 540 2 2014 210 216
114. M.R. Meyer, K. Amann, A.S. Field, C. Hu, H.J. Hathaway, N.L. Kanagy, M.K. Walker, M. Barton, and E.R. Prossnitz Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction Hypertension 59 2012 507 512
115. M.R. Meyer, A.S. Field, N.L. Kanagy, M. Barton, and E.R. Prossnitz GPER regulates endothelin-dependent vascular tone and intracellular calcium Life Sci. 91 13-14 2012 623 627
116. M.R. Meyer, N.C. Fredette, M. Barton, and E.R. Prossnitz Regulation of vascular smooth muscle tone by adipose-derived contracting factor PLoS ONE 8 11 2013 e79245
117. S.H. Lindsey, L. Liu, and M.C. Chappell Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling Steroids 81 2013 99 102
118. S.H. Lindsey, A.S. da Silva, M.S. Silva, and M.C. Chappell Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation Am. J. Physiol. Endocrinol. Metab. 305 1 2013 E113 E118
119. S.H. Lindsey, K.A. Carver, E.R. Prossnitz, and M.C. Chappell Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2. Lewis female rat J. Cardiovasc. Pharmacol. 57 5 2011 598 603
120. J.A. Jessup, S.H. Lindsey, H. Wang, M.C. Chappell, and L. Groban Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2. Lewis rats PLoS ONE 5 11 2011 e15433
121. S.H. Lindsey, J.A. Cohen, K.B. Brosnihan, P.E. Gallagher, and M.C. Chappell Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2. Lewis rats Endocrinology 150 8 2009 3753 3758
122. R.D. Feldman, R. Gros, Q. Ding, Y. Hussain, M.R. Ban, A.D. McIntyre, and R.A. Hegele A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women Br. J. Clin. Pharmacol. 78 6 2014 1441 1452
123. M. Barton Cholesterol and atherosclerosis: modulation by oestrogen Curr. Opin. Lipidol. 24 3 2013 214 220
124. M.R. Meyer, N.C. Fredette, T.A. Howard, C. Hu, C. Ramesh, C. Daniel, K. Amann, J.B. Arterburn, M. Barton, and E.R. Prossnitz G protein-coupled estrogen receptor protects from atherosclerosis Sci. Rep. 4 2014 7564
125. J.C. Bopassa, L.F. Leeb-Lundberg, B. Olde, L. Toro, and E. Stefani Loss of rapid estrogen-Induced cardioprotection in GPER-/- mice after ischemia and reperfusion Biophys. J. 100 3, Suppl. 1 2011 294a 295a
126. J.C. Bopassa, M. Eghbali, L. Toro, and E. Stefani A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 298 1 2010 H16 H23
127. A.M. Deschamps, and E. Murphy Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats Am. J. Physiol. Heart Circ. Physiol. 297 5 2009 H1806 H1813
128. B.R. Weil, M.C. Manukyan, J.L. Herrmann, Y. Wang, A.M. Abarbanell, J.A. Poynter, and D.R. Meldrum Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury Surgery 148 2 2010 436 443
129. H. Wang, J.A. Jessup, M.S. Lin, C. Chagas, S.H. Lindsey, and L. Groban Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2. Lewis rats Cardiovasc. Res. 94 1 2012 96 104
130. S. Kang, Y. Liu, D. Sun, C. Zhou, A. Liu, C. Xu, Y. Hao, D. Li, C. Yan, and H. Sun Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure PLoS ONE 7 10 2012 e48185
131. S.B. Cheng, J. Dong, Y. Pang, J. LaRocca, M. Hixon, P. Thomas, and E.J. Filardo Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone Mol. Cell. Endocrinol. 382 2 2014 950 959
132. M.V. Hofmeister, H.H. Damkier, B.M. Christensen, B. Olde, L.M. Fredrik Leeb-Lundberg, R.A. Fenton, H.A. Praetorius, and J. Praetorius 17beta-estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1 Am. J. Physiol. Renal Physiol. 302 3 2012 F358 368
133. S.H. Lindsey, and M.C. Chappell GPR30 activation in salt-sensitive mRen2. Lewis females induces beneficial effects independent of alterations in blood pressure FASEB J. 2009 1017.1018
134. S.H. Lindsey, L.M. Yamaleyeva, K.B. Brosnihan, P.E. Gallagher, and M.C. Chappell Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2. Lewis rat Hypertension 58 4 2011 665 671
135. M.P. Hutchens, T. Nakano, Y. Kosaka, J. Dunlap, W. Zhang, P.S. Herson, S.J. Murphy, S. Anderson, and P.D. Hurn Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo Anesthesiology 112 2 2010 395 405
136. M.P. Hutchens, Y. Kosaka, W. Zhang, T. Fujiyoshi, S. Murphy, N. Alkayed, and S. Anderson Estrogen-mediated renoprotection following cardiac arrest and cardiopulmonary resuscitation is robust to GPR30 gene deletion PLoS ONE 9 6 2014 e99910
137. M.R. Meyer, D.J. Clegg, E.R. Prossnitz, and M. Barton Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors Acta Physiol. (Oxf.) 203 1 2011 259 269
138. Y. Hussain, Q. Ding, P.W. Connelly, J.H. Brunt, M.R. Ban, A.D. McIntyre, M.W. Huff, R. Gros, R.A. Hegele, and R.D. Feldman G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies Arterioscler. Thromb. Vasc. Biol. 35 1 2015 213 221
139. K.E. Davis, E.J. Carstens, B.G. Irani, L.M. Gent, L.M. Hahner, and D.J. Clegg Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis Horm. Behav. 66 1 2014 196 207
140. O. Kwon, E.S. Kang, I. Kim, S. Shin, M. Kim, S. Kwon, S.R. Oh, Y.S. Ahn, and C.H. Kim GPR30 mediates anorectic estrogen-induced STAT3 signaling in the hypothalamus Metabolism 63 11 2014 1455 1461
141. P. Zhu, J.M. Yuen, K.W. Sham, and C.H. Cheng GPER mediates the inhibitory actions of estrogen on adipogenesis in 3T3-L1 cells through perturbation of mitotic clonal expansion Gen. Comp. Endocrinol. 193 2013 19 26
142. J.P. Tiano, V. Delghingaro-Augusto, C. Le May, S. Liu, M.K. Kaw, S.S. Khuder, M.G. Latour, S.A. Bhatt, K.S. Korach, S.M. Najjar, M. Prentki, and F. Mauvais-Jarvis Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes J. Clin. Invest. 121 8 2011 3331 3342
143. W.P. Wong, J.P. Tiano, S. Liu, S.C. Hewitt, C. Le May, S. Dalle, J.A. Katzenellenbogen, B.S. Katzenellenbogen, K.S. Korach, and F. Mauvais-Jarvis Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis Proc. Natl. Acad. Sci. U. S. A. 107 29 2010 13057 13062
144. A. Nadal, P. Alonso-Magdalena, S. Soriano, A.B. Ropero, and I. Quesada The role of oestrogens in the adaptation of islets to insulin resistance J. Physiol 587 2009 5031 5037 Pt 21
145. A. Nadal, P. Alonso-Magdalena, S. Soriano, I. Quesada, and A.B. Ropero The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes Mol. Cell. Endocrinol. 304 1-2 2009 63 68
146. I.F. Godsland Oestrogens and insulin secretion Diabetologia 48 11 2005 2213 2220
147. J.P. Tiano, and F. Mauvais-Jarvis Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes Nat. Rev. Endocrinol. 8 6 2012 342 351
148. S. Liu, G. Kilic, M.S. Meyers, G. Navarro, Y. Wang, J. Oberholzer, and F. Mauvais-Jarvis Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes Diabetologia 56 2 2013 370 381
149. J.P. Tiano, and F. Mauvais-Jarvis Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic beta-cells Endocrinology 153 7 2012 2997 3005
150. G. Sharma, and E.R. Prossnitz Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells Endocrinology 152 8 2011 3030 3039
151. C.W. Daniel, G.B. Silberstein, and P. Strickland Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography Cancer Res. 47 22 1987 6052 6057
152. G.M. Higa, and R.G. Fell Sex hormone receptor repertoire in breast cancer Int. J. Breast Cancer 2013 2013 284036
153. F. Cordera, and V.C. Jordan Steroid receptors and their role in the biology and control of breast cancer growth Semin. Oncol. 33 6 2006 631 641
154. M. Dowsett, J. Cuzick, J. Ingle, A. Coates, J. Forbes, J. Bliss, M. Buyse, M. Baum, A. Buzdar, M. Colleoni, C. Coombes, C. Snowdon, M. Gnant, R. Jakesz, M. Kaufmann, F. Boccardo, J. Godwin, C. Davies, and R. Peto Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen J. Clin. Oncol. 28 3 2010 509 518
155. D.P. Pandey, R. Lappano, L. Albanito, A. Madeo, M. Maggiolini, and D. Picard Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF EMBO J. 28 5 2009 523 532
156. R. Girgert, G. Emons, and C. Grundker Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy Breast Cancer Res. Treat. 134 1 2012 199 205
157. A. Ignatov, T. Ignatov, A. Roessner, S.D. Costa, and T. Kalinski Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells Breast Cancer Res. Treat. 123 1 2010 87 96
158. E.J. Filardo, C.T. Graeber, J.A. Quinn, M.B. Resnick, D. Giri, R.A. DeLellis, M.M. Steinhoff, and E. Sabo Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression Clin. Cancer Res. 12 21 2006 6359 6366
159. A. Ignatov, T. Ignatov, C. Weissenborn, H. Eggemann, J. Bischoff, A. Semczuk, A. Roessner, S.D. Costa, and T. Kalinski G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer Breast Cancer Res. Treat. 128 2 2011 457 466
160. N.A. Marjon, C. Hu, H.J. Hathaway, and E.R. Prossnitz G protein-coupled estrogen receptor (GPER) regulates mammary tumorigenesis and metastasis Mol. Cancer Res. 12 11 2014 1644 1654
161. C.T. Guy, R.D. Cardiff, and W.J. Muller Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease Mol. Cell. Biol. 12 3 1992 954 961
162. E.Y. Lin, J.G. Jones, P. Li, L. Zhu, K.D. Whitney, W.J. Muller, and J.W. Pollard Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases Am. J. Pathol. 163 5 2003 2113 2126
163. R. Namba, L.J. Young, J.E. Maglione, E.T. McGoldrick, S. Liu, G.T. Wurz, M.W. DeGregorio, A.D. Borowsky, C.L. MacLeod, R.D. Cardiff, and J.P. Gregg Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ Breast Cancer Res. 7 6 2005 R881 889
164. C. Dabrosin, K. Palmer, W.J. Muller, and J. Gauldie Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants Breast Cancer Res. Treat. 78 2003 1 6
165. J.E. Maglione, D. Moghanaki, L.J. Young, C.K. Manner, L.G. Ellies, S.O. Joseph, B. Nicholson, R.D. Cardiff, and C.L. MacLeod Transgenic polyoma middle-T mice model premalignant mammary disease Cancer Res. 61 22 2001 8298 8305
166. M.M. Fluck, and B.S. Schaffhausen Lessons in signaling and tumorigenesis from polyomavirus middle T antigen Microbiol. Mol. Biol. Rev. 73 3 2009 542 563 Table of contents
167. W.T. Creasman, J.T. Soper, K.S.K.S. McCarty McCarty Jr., W. Hinshaw Sr., and D.L. Clarke-Pearson Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma Am. J. Obstet. Gynecol. 151 7 1985 922 932
168. S.M. Ho Estrogen, progesterone and epithelial ovarian cancer Reprod. Biol. Endocrinol. 1 2003 73
169. H.O. Smith, H. Arias-Pulido, D.Y. Kuo, T. Howard, C.R. Qualls, S.J. Lee, C.F. Verschraegen, H.J. Hathaway, N.E. Joste, and E.R. Prossnitz GPR30 predicts poor survival for ovarian cancer Gynecol. Oncol. 114 3 2009 465 471
170. H.O. Smith, K.K. Leslie, M. Singh, C.R. Qualls, C.M. Revankar, N.E. Joste, and E.R. Prossnitz GPR30: a novel indicator of poor survival for endometrial carcinoma Am. J. Obstet. Gynecol. 386 2007 e1 e9
171. Q.G. Zhang, R. Wang, H. Tang, Y. Dong, A. Chan, G.R. Sareddy, R.K. Vadlamudi, and D.W. Brann Brain-derived estrogen exerts anti-inflammatory and neuroprotective actions in the rat hippocampus Mol. Cell. Endocrinol. 389 1-2 2014 84 91
172. R. Hammond, and R.B. Gibbs GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance Brain Res. 1379 2011 53 60
173. E. Brailoiu, S.L. Dun, G.C. Brailoiu, K. Mizuo, L.A. Sklar, T.I. Oprea, E.R. Prossnitz, and N.J. Dun Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system J. Endocrinol. 193 2 2007 311 321
174. S.L. Dun, G.C. Brailoiu, X. Gao, E. Brailoiu, J.B. Arterburn, E.R. Prossnitz, T.I. Oprea, and N.J. Dun Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia J. Neurosci. Res. 87 2009 1610 1619
175. G.G. Hazell, S.T. Yao, J.A. Roper, E.R. Prossnitz, A.M. O'Carroll, and S.J. Lolait Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues J. Endocrinol. 202 2 2009 223 236
176. J. Qiu, M.A. Bosch, S.C. Tobias, A. Krust, S.M. Graham, S.J. Murphy, K.S. Korach, P. Chambon, T.S. Scanlan, O.K. Ronnekleiv, and M.J. Kelly A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis J. Neurosci. 26 21 2006 5649 5655
177. J. Qiu, O.K. Ronnekleiv, and M.J. Kelly Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor Steroids 73 9-10 2008 985 991
178. I. Kastenberger, and C. Schwarzer GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner Horm. Behav. 66 4 2014 628 636
179. J. Kuhn, O.A. Dina, C. Goswami, V. Suckow, J.D. Levine, and T. Hucho GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat Eur. J. Neurosci. 27 7 2008 1700 1709
180. C.L. Lu, J.C. Hsieh, N.J. Dun, T.I. Oprea, P.S. Wang, J.C. Luo, H.C. Lin, F.Y. Chang, and S.D. Lee Estrogen rapidly modulates 5-hydroxytrytophan-induced visceral hypersensitivity via GPR30 in rats Gastroenterology 137 3 2009 1040 1050
181. D. Lebesgue, M. Traub, M. De Butte-Smith, C. Chen, R.S. Zukin, M.J. Kelly, and A.M. Etgen Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats PLoS ONE 5 1 2010 e8642
182. D. Lebesgue, V. Chevaleyre, R.S. Zukin, and A.M. Etgen Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection Steroids 74 7 2009 555 561
183. T. Murata, H.H. Dietrich, C. Xiang, and R.G. Dacey Jr. G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats Stroke 44 3 2013 779 785
184. B. Zhang, S. Subramanian, S. Dziennis, J. Jia, M. Uchida, K. Akiyoshi, E. Migliati, A.D. Lewis, A.A. Vandenbark, H. Offner, and P.D. Hurn Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke J. Immunol. 184 8 2010 4087 4094
185. H. Xu, S. Qin, G.A. Carrasco, Y. Dai, E.J. Filardo, E.R. Prossnitz, G. Battaglia, L.L. Doncarlos, and N.A. Muma Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus Neuroscience 158 4 2009 1599 1607
186. D. Lebesgue, A. Reyna-Neyra, X. Huang, and A.M. Etgen GPR30 differentially regulates short latency responses of luteinising hormone and prolactin secretion to oestradiol J. Neuroendocrinol. 21 9 2009 743 752
187. D. Anchan, A. Gafur, K. Sano, S. Ogawa, and N. Vasudevan Activation of the GPR30 receptor promotes lordosis in female mice Neuroendocrinology 100 1 2014 71 80
188. A.M. Etgen, T. Jover-Mengual, and R. Suzanne Zukin Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: Translational implications Front. Neuroendocrinol. 32 3 2011 336 352
189. Y. Imai, S. Kondoh, A. Kouzmenko, and S. Kato Regulation of bone metabolism by nuclear receptors Mol. Cell. Endocrinol. 310 1-2 2009 3 10
190. S. Khosla Update on estrogens and the skeleton J. Clin. Endocrinol. Metab. 95 8 2010 3569 3577
191. C. Ohlsson, and L. Vandenput The role of estrogens for male bone health Eur. J. Endocrinol. 160 6 2009 883 889
192. A.S. Chagin, and L. Savendahl GPR 30 estrogen receptor expression in the growth plate declines as puberty progresses J. Clin. Endocrinol. Metab. 92 12 2007 4873 4877
193. T.J. Heino, A.S. Chagin, and L. Savendahl The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone J. Endocrinol. 197 2 2008 R1 R6
194. N.M. Teplyuk, M. Galindo, V.I. Teplyuk, J. Pratap, D.W. Young, D. Lapointe, A. Javed, J.L. Stein, J.B. Lian, G.S. Stein, and A.J. van Wijnen Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors J. Biol. Chem. 283 41 2008 27585 27597
195. J. Ford, A. Hajibeigi, M. Long, L. Hahner, C. Gore, J.T. Hsieh, D. Clegg, J. Zerwekh, and O.K. Oz GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice J. Bone Miner. Res. 26 2 2011 298 307
196. A.F. Eisener-Dorman, D.A. Lawrence, and V.J. Bolivar Cautionary insights on knockout mouse studies: the gene or not the gene Brain. Behav. Immun. 23 3 2009 318 324
197. N.C. Fredette, M.R. Meyer, E.R. Prossnitz, The G protein-coupled receptor (GPER/GPR30) activates endothelial nitric oxide synthase 1075.5, EB14, San Diego, CA, 2014.
198. G. Developmental Endocrinology Studies R.R. Newbold, W.N. Jefferson, E. Padilla-Banks, V.R. Walker, and D.S. Pena Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay Reprod. Toxicol. 15 3 2001 245 252